Tekla Life Sciences Investors
Location
Massachusetts
Founded
2000-01-26
Website
Risk Signals
155 news mentions monitored
Industry Context
This company is tracked across risk categories, including those related to its sector (e.g., Management Investment Offices, Open-End), including supply chain integrity, ESG practices, labor disputes, and regulatory compliance.
Filter risk signals by topic
Select a theme below to explore the company’s news mentions in specific risk areas.
Recent Articles about Tekla Life Sciences Investors
Live alerts from global media, monitored by Business Radar
2023-11-30 (marketbeat.com)
Johnson & Johnson (NYSE:JNJ) Stock Position Raised by Graham Capital Management L.P.
Graham Capital Management L.P. raised its stake in Johnson & Johnson (NYSE:JNJ - Free Report) by 108.3% in the second quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 108,569 shares of the company's stock after acquiring a
Read more
2023-10-09 (defenseworld.net)
Johnson & Johnson (NYSE:JNJ) Shares Bought by RNC Capital Management LLC
RNC Capital Management LLC raised its stake in Johnson & Johnson (NYSE:JNJ – Free Report) by 0.3% during the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC).
Read more
2023-09-29 (marketbeat.com)
Lbmc Investment Advisors LLC Acquires 1,287 Shares of Johnson & Johnson (NYSE:JNJ)
Lbmc Investment Advisors LLC grew its holdings in Johnson & Johnson (NYSE:JNJ - Free Report) by 21.4% in the 2nd quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 7,294 shares of the company's stock after purchasing an additional 1,287 s
Read more
2023-09-29 (marketbeat.com)
Lbmc Investment Advisors LLC Acquires 1,287 Shares of Johnson & Johnson (NYSE:JNJ)
Lbmc Investment Advisors LLC grew its holdings in Johnson & Johnson (NYSE:JNJ - Free Report) by 21.4% in the 2nd quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 7,294 shares of the company's stock after purchasing an additional 1,287 s
Read more
2023-09-29 (marketbeat.com)
Lbmc Investment Advisors LLC Acquires 1,287 Shares of Johnson & Johnson (NYSE:JNJ)
Lbmc Investment Advisors LLC grew its holdings in Johnson & Johnson (NYSE:JNJ - Free Report) by 21.4% in the 2nd quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 7,294 shares of the company's stock after purchasing an additional 1,287 s
Read more
2023-09-21 (yahoo.com)
Insider Buying: President Daniel Omstead Acquires 12,000 Shares of Tekla Life Sciences ...
On September 20, 2023, President Daniel Omstead of Tekla Life Sciences Investors (NYSE:HQL) made a significant purchase of 12,000 shares of the company's stock.
Read more
2023-06-30 (nasdaq.com)
Tekla Capital Management LLC Announces Closing of Transaction With abrdn
Tekla Capital Management LLC announced today that it has completed the sale of its advisory business to abrdn Inc. In addition, effective close of regular business, abrdn was approved as manager to four NYSE listed healthcare and biotech thematic closed-end funds, totaling$ 2.8 bn in assets under
Read more
2023-06-30 (nasdaq.com)
Tekla Capital Management LLC Announces Closing of Transaction With abrdn
Tekla Capital Management LLC announced today that it has completed the sale of its advisory business to abrdn Inc. In addition, effective close of regular business, abrdn was approved as manager to four NYSE listed healthcare and biotech thematic closed-end funds, totaling$ 2.8 bn in assets under
Read more
2023-06-20 (yahoo.com)
abrdn to Acquire US Specialist Healthcare Closed-End Funds with $3 Billion AUM
abrdn plc today announced that its U.S. subsidiary abrdn Inc. has entered into an agreement to acquire the healthcare fund management capabilities of Tekla Capital Management LLC (Tekla), a global specialist healthcare investment adviser based in Boston, Massachusetts.
Read more
2023-06-20 (yahoo.com)
abrdn to Acquire US Specialist Healthcare Closed-End Funds with $3 Billion AUM
abrdn plc today announced that its U.S. subsidiary abrdn Inc. has entered into an agreement to acquire the healthcare fund management capabilities of Tekla Capital Management LLC (Tekla), a global specialist healthcare investment adviser based in Boston, Massachusetts.
Read more
2023-06-20 (yahoo.com)
abrdn to Acquire US Specialist Healthcare Closed-End Funds with $3 Billion AUM
abrdn plc today announced that its U.S. subsidiary abrdn Inc. has entered into an agreement to acquire the healthcare fund management capabilities of Tekla Capital Management LLC (Tekla), a global specialist healthcare investment adviser based in Boston, Massachusetts.
Read more
2023-01-20 (reporter.am)
Janney Montgomery Scott LLC Buys 8,872 Shares of Tekla Life Sciences Investors (NYSE:HQL)
Janney Montgomery Scott LLC boosted its stake in Tekla Life Sciences Investors (NYSE:HQL – Get Rating) by 19.0% in the 3rd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC).
Read more